Document is current
Any future updates will be listed below
-
Authors
Bjørnstad, Herman
Frigaard, Christine
Gulbrandsen, Pål
Gerwing, Jennifer
Schirmer, Henrik
Menichetti, Julia
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 11 September 2025
First Online: 1 October 2025
Declarations
:
: No support from any organization for the submitted work; HS has received lecture fees from Amgen, Boehringer Ingelheim, Novartis, Novo-Nordisk and Sanofi-Aventis; PG has received lecture fees from Norwegian Brain Tumor Society, Pfizer and Takeda; JM is a member of Advisory Committee and Board of Trustees for the International Association for Communication in Healthcare EACH (unpaid), and received lecture fees from Oslo Metropolitan University and EACH; no other relationships or activities that could appear to have influenced the submitted work.
: The authors declare no competing interests.
